CD40 signal regulates CXCR4 mediating ovarian carcinoma cell migration: Implications for extrapelvic metastastic factors

Oncology Research

Volumn 20, Issue 9, 2013, Pages 383-392

  Qu, Qiu Xia ^a,b   Huang, Qin ^a   Xu, Jian ^a,b   Duan, Li Ting ^a   Zhu, Yi Bei ^b   Zhang, Xue Guang ^a,b  

^a SOOCHOW UNIVERSITY   (China)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

CD40; CXCR4; Migration; Ovarian cancer; Pelvic metastasis

Indexed keywords

CD40 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; FEMALE; HUMAN; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

EID: 84880323110     PISSN: 09650407     EISSN: 15553906     Source Type: Journal    
DOI: 10.3727/096504013X13657689382653     Document Type: Article

References (25)

1. McCluggage, W. G. Morphological subtypes of ovarian carcinoma: A review with emphasis on new developments and pathogenesis. Pathology 43:420-432;2011.
2. Saad, A. F.; Hu, W.; Sood, A. K. Microenvironment and pathogenesis of epithelial ovarian cancer. Horm. Cancer 1:277-290;2010.
3. Kim, M.; Koh, Y. J.; Kim, K. E.; Koh, B. I.; Nam, D. H.; Alitalo, K.; Kim, I.; Koh, G. Y. CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche. Cancer Res. 70:10411-10421;2010.
4. Li, X.; Ma, Q.; Xu, Q.; Liu, H.; Lei, J.; Duan, W.; Bhat, K.; Wang, F.; Wu, E.; Wang, Z. SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through noncanonical activation of Hedgehog pathway. Cancer Lett. 322:169-176;2012.
5. Beider, K.; Begin, M.; Abraham, M.; Wald, H.; Weiss, I. D.; Wald, O.; Pikarsky, E.; Zeira, E.; Eizenberg, O.; Galun, E.; Hardan, I.; Engelhard, D.; Nagler, A.; Peled, A. CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growth. Exp. Hematol. 39:282-292;2011.
6. Rhodes, L. V.; Short, S. P.; Neel, N. F.; Salvo, V. A.; Zhu, Y.; Elliott, S.; Wei, Y.; Yu, D.; Sun, M.; Muir, S. E.; Fonseca, J. P.; Bratton, M. R.; Segar, C.; Tilghman, S. L.; Sobolik-Delmaire, T.; Horton, L. W.; Zaja-Milatovic, S.; Collins-Burow, B. M.; Wadsworth, S.; Beckman, B. S.; Wood, C. E.; Fuqua, S. A.; Nephew, K. P.; Dent, P.; Worthylake, R. A.; Curiel, T. J.; Hung, M. C.; Richmond, A.; Burow, M. E. Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer. Cancer Res. 71:603-613;2011.
7. Miyanishi, N.; Suzuki, Y.; Simizu, S.; Kuwabara, Y.; Banno, K.; Umezawa, K. Involvement of autocrine CXCL12/CXCR4 system in the regulation of ovarian carcinoma cell invasion. Biochem. Biophys. Res. Commun. 403:154-159;2010.
8. Kukreja, P.; Abdel-Mageed, A. B.; Monda, L. D.; Liu, K.; Agrawal, K. C. Upregulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1α (CXCL12) increases endothelial adhesion and transendothelial migration: Role of MEK/ERK signaling pathway-dependent NF-κB activation. Cancer Res. 65:9891-9898;2005.
9. Bergmann, S.; Pandolfi, P. Giving blood: A new role for CD40 in tumorigenesis. J. Exp. Med. 203:2409-2412;2006.
10. Melter, M.; Reinders, M. E.; Sho, M.; Pal, S.; Geehan, C.; Denton, M. D.; Mukhopadhyay, D.; Briscoe, D. M. Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood 96:3801-3808;2000.
11. Imadome, K.; Shimizu, N.; Yajima, M.; Watanabe, K.; Nakamura, H.; Takeuchi, H.; Fujiwara, S. CD40 signaling activated by Epstein-Barr virus promotes cell survival and proliferation in gastric carcinoma-derived human epithelial cells. Microbes Infect. 11:429-433;2009.
12. Zhou, Z. H.; Wang, J. F.; Wang, Y. D.; Qiu, Y. H.; Pan, J. Z.; Xie, W.; Jiang, L. Y.; Klein, B.; Zhang, X. G. An agonist anti-human CD40 monoclonal antibody that induces dendritic cell formation and maturation and inhibits proliferation of a myeloma cell line. Hybridoma 18:471-478;1999.
13. De Oliveira, K. B.; Guembarovski, R. L.; Guembarovski, A. M.; Da Silva do Amaral Herrera, A. C.; Sobrinho, W. J.; Ariza, C. B.; Watanabe, M. A. CXCL12, CXCR4 and IFN-γ genes expression: Implications for proinflammatory microenvironment of breast cancer. Clin. Exp. Med. in press.
14. Lee, H. J.; Lee, K.; Lee, D. G.; Bae, K. H.; Kim, J. S.; Liang, Z. L.; Huang, S. M.; Suk, O. H. Y.; Kim, H. Y.; Jo, D. Y.; Min, J. K.; Kim, J. M.; Lee, H. J. Chemokine (C-X-C Motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor. Clin. Cancer Res. 18:3270-3280;2012.
15. Paratore, S.; Banna, G. L.; D'Arrigo, M.; Saita, S.; Iemmolo, R.; Lucenti, L.; Bellia, D.; Lipari, H.; Buscarino, C.; Cunsolo, R.; Cavallaro, S. CXCR4 and CXCL12 immunoreactivities differentiate primary nonsmall-cell lung cancer with or without brain metastases. Cancer Biomark. 10:79-89;2011.
16. Monteagudo, C.; Ramos, D.; Pellín-Carcelén, A.; Gil, R.; Callaghan, R. C.; Martín, J. M.; Alonso, V.; Murgui, A.; Navarro, L.; Calabuig, S.; López-Guerrero, J. A.; Jordá, E.; Pellín, A. CCL27-CCR10 and CXCL12-CXCR4 chemokine ligand-receptor mRNA expression ratio: New predictive factors of tumor progression in cutaneous malignant melanoma. Clin. Exp. Metastasis 29:625-637;2012.
17. Büning, C.; Krüger, K.; Sieber, T.; Schoeler, D.; Schriever, F. Increased expression of CD40 ligand on activated T-cells of patients with colon cancer. Clin. Cancer Res. 8:1147-1151;2002.
18. Chakrabarti, S.; Blair, P.; Freedman, J. E. CD40-40L signaling in vascular inflammation. J. Biol. Chem. 282:18307-18317;2007.
19. Chiodoni, C.; Iezzi, M.; Guiducci, C.; Sangaletti, S.; Alessandrini, I.; Ratti, C.; Tiboni, F.; Musiani, P.; Granger, D. N.; Colombo, M. P. Triggering CD40 on endothelial cells contributes to tumor growth. J. Exp. Med. 203:2441-2450;2006.
20. Rizvi, M.; Pathak, D.; Freedman, J. E.; Chakrabarti, S. CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease. Trends Mol. Med. 14:530-538;2008.
21. Feng, Y.; Hu, J.; Ma, J.; Feng, K.; Zhang, X.; Yang, S.; Wang, W.; Zhang, J.; Zhang, Y. RNAi-mediated silencing of VEGF-C inhibits nonsmall cell lung cancer progression by simultaneously downregulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways. Eur. J. Cancer 47:2353-2363;2011.
22. Ping, Y. F.; Yao, X. H.; Jiang, J. Y.; Zhao, L. T.; Yu, S. C.; Jiang, T.; Lin, M. C.; Chen, J. H.; Wang, B.; Zhang, R.; Cui, Y. H.; Qian, C.; Wang, J.; Bian, X. W. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cellmediated VEGF production and tumour angiogenesis via PI3K/AKT signalling. J. Pathol. 224:344-354;2011.
23. De Nigris, F.; Crudele, V.; Giovane, A.; Casamassimi, A.; Giordano, A.; Garban, H. J.; Cacciatore, F.; Pentimalli, F.; Marquez-Garban, D. C.; Petrillo, A.; Cito, L.; Sommese, L.; Fiore, A.; Petrillo, M.; Siani, A.; Barbieri, A.; Arra, C.; Rengo, F.; Hayashi, T.; Al-Omran, M.; Ignarro, L. J.; Napoli, C. CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy. Proc. Natl. Acad. Sci. USA 107:14484-14489;2010.
24. Wang, Q.; Diao, X.; Sun, J.; Chen, Z. Regulation of VEGF, MMP-9 and metastasis by CXCR4 in a prostate cancer cell line. Cell. Biol. Int. 35:897-904;2011.
25. Xie, F.; Shi, Q.; Wang, Q.; Ge, Y.; Chen, Y.; Zuo, J.; Gu, Y.; Deng, H.; Mao, H.; Hu, Z.; Zhou, Y.; Zhang, X. G. CD40 is a regulator for vascular endothelial growth factor in the tumor microenvironment of glioma. J. Neuroimmunol. 222:62-69;2010.